Covance "Team IND" approach to cutting preclinical time period modeled on U.K. project.
COVANCE "TEAM IND" PRECLINICAL PROJECT IS MODELED ON U.K. EXPERIENCE that has shortened the average period of testing prior to Phase I to about half a year. Covance, nee Corning Pharmaceutical Services , maintains that it has developed a fast-track program bridging the specialties of preclinical testing and the first phases of human testing and used it on more than 10 drug compounds in the U.K. Covance is calling the integrated preclinical approach a Strategic Product Development program.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth